Free Trial

908 Devices Q1 2023 Earnings Report

908 Devices logo
$2.06 +0.12 (+6.19%)
(As of 12/20/2024 05:16 PM ET)

908 Devices EPS Results

Actual EPS
-$0.39
Consensus EPS
-$0.35
Beat/Miss
Missed by -$0.04
One Year Ago EPS
-$0.30

908 Devices Revenue Results

Actual Revenue
$9.50 million
Expected Revenue
$8.65 million
Beat/Miss
Beat by +$850.00 thousand
YoY Revenue Growth
+14.50%

908 Devices Announcement Details

Quarter
Q1 2023
Time
Before Market Opens

Conference Call Resources

Conference Call Audio

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>

908 Devices Earnings Headlines

908 Devices, Getinge enter Maven integration collaboration
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
Boston firm to shift manufacturing to North Carolina
See More 908 Devices Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 908 Devices? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 908 Devices and other key companies, straight to your email.

About 908 Devices

908 Devices (NASDAQ:MASS), a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

View 908 Devices Profile

More Earnings Resources from MarketBeat

Upcoming Earnings